These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37701149)

  • 1. Hypervitaminosis D Secondary to a
    Collins L; Boehm E; Luxford C; Clifton-Bligh R; Grill V
    JBMR Plus; 2023 Sep; 7(9):e10788. PubMed ID: 37701149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP24A1 loss of function: Clinical phenotype of monoallelic and biallelic mutations.
    Carpenter TO
    J Steroid Biochem Mol Biol; 2017 Oct; 173():337-340. PubMed ID: 28093352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent hypercalcaemia associated with two pathogenic variants in the
    Leszczyńska D; Szatko A; Latocha J; Kochman M; Duchnowska M; Wójcicka A; Misiorowski W; Zgliczyníski W; Glinicki P
    Front Endocrinol (Lausanne); 2024; 15():1355916. PubMed ID: 38665259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kidney function and influence of sunlight exposure in patients with impaired 24-hydroxylation of vitamin D due to CYP24A1 mutations.
    Figueres ML; Linglart A; Bienaime F; Allain-Launay E; Roussey-Kessler G; Ryckewaert A; Kottler ML; Hourmant M
    Am J Kidney Dis; 2015 Jan; 65(1):122-6. PubMed ID: 25446019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss-of-function mutations of CYP24A1, the vitamin D 24-hydroxylase gene, cause long-standing hypercalciuric nephrolithiasis and nephrocalcinosis.
    Dinour D; Beckerman P; Ganon L; Tordjman K; Eisenstein Z; Holtzman EJ
    J Urol; 2013 Aug; 190(2):552-7. PubMed ID: 23470222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intractable hypercalcaemia during pregnancy and the postpartum secondary to pathogenic variants in CYP24A1.
    Arnold N; O'Toole V; Huynh T; Smith HC; Luxford C; Clifton-Bligh R; Eastman CJ
    Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31751313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential diagnosis of vitamin D-related hypercalcemia using serum vitamin D metabolite profiling.
    Kaufmann M; Schlingmann KP; Berezin L; Molin A; Sheftel J; Vig M; Gallagher JC; Nagata A; Masoud SS; Sakamoto R; Nagasawa K; Uesugi M; Kottler ML; Konrad M; Jones G
    J Bone Miner Res; 2021 Jul; 36(7):1340-1350. PubMed ID: 33856702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy.
    Tebben PJ; Milliner DS; Horst RL; Harris PC; Singh RJ; Wu Y; Foreman JW; Chelminski PR; Kumar R
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E423-7. PubMed ID: 22337913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal Hypercalcemia Due to Failure of 1,25-Dihydroxyvitamin-D3 Catabolism in a Patient With CYP24A1 Mutations.
    Shah AD; Hsiao EC; O'Donnell B; Salmeen K; Nussbaum R; Krebs M; Baumgartner-Parzer S; Kaufmann M; Jones G; Bikle DD; Wang Y; Mathew AS; Shoback D; Block-Kurbisch I
    J Clin Endocrinol Metab; 2015 Aug; 100(8):2832-6. PubMed ID: 26097993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and biochemical phenotypes of adults with monoallelic and biallelic CYP24A1 mutations: evidence of gene dose effect.
    O'Keeffe DT; Tebben PJ; Kumar R; Singh RJ; Wu Y; Wermers RA
    Osteoporos Int; 2016 Oct; 27(10):3121-5. PubMed ID: 27129455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3' Untranslated Region Structural Elements in CYP24A1 Are Associated With Infantile Hypercalcemia Type 1.
    Ball N; Duncan S; Zhang Y; Payet R; Piec I; Whittle E; Tang JCY; Schoenmakers I; Lopez B; Chipchase A; Kumar A; Perry L; Maxwell H; Ding Y; Fraser WD; Green D
    J Bone Miner Res; 2023 Mar; 38(3):414-426. PubMed ID: 36625425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hereditary Hypercalcemia Caused by a Homozygous Pathogenic Variant in the
    Cappellani D; Brancatella A; Kaufmann M; Minucci A; Vignali E; Canale D; De Paolis E; Capoluongo E; Cetani F; Jones G; Marcocci C
    Case Rep Endocrinol; 2019; 2019():4982621. PubMed ID: 31089432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.
    Tebben PJ; Singh RJ; Kumar R
    Endocr Rev; 2016 Oct; 37(5):521-547. PubMed ID: 27588937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium and bone homeostasis in heterozygous carriers of CYP24A1 mutations: A cross-sectional study.
    Cools M; Goemaere S; Baetens D; Raes A; Desloovere A; Kaufman JM; De Schepper J; Jans I; Vanderschueren D; Billen J; De Baere E; Fiers T; Bouillon R
    Bone; 2015 Dec; 81():89-96. PubMed ID: 26117226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis.
    Nesterova G; Malicdan MC; Yasuda K; Sakaki T; Vilboux T; Ciccone C; Horst R; Huang Y; Golas G; Introne W; Huizing M; Adams D; Boerkoel CF; Collins MT; Gahl WA
    Clin J Am Soc Nephrol; 2013 Apr; 8(4):649-57. PubMed ID: 23293122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hypercalcaemia from inactivating mutations of vitamin D 24-hydroxylase (CYP24A1): implications for mineral metabolism changes in chronic renal failure.
    Colussi G; Ganon L; Penco S; De Ferrari ME; Ravera F; Querques M; Primignani P; Holtzman EJ; Dinour D
    Nephrol Dial Transplant; 2014 Mar; 29(3):636-43. PubMed ID: 24235083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP24A1 and SLC34A1 Pathogenic Variants Are Uncommon in a Canadian Cohort of Children with Hypercalcemia or Hypercalciuria.
    Rousseau-Nepton I; Jones G; Schlingmann K; Kaufmann M; Zuijdwijk CS; Khatchadourian K; Gupta IR; Pacaud D; Pinsk MN; Mokashi A; Nour MA; Alexander RT; Rodd CJ
    Horm Res Paediatr; 2021; 94(3-4):124-132. PubMed ID: 34320495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic infantile hypercalcemia: mutations in SLC34A1 and CYP24A1 in two siblings and fathers.
    Güven A; Konrad M; Schlingmann KP
    J Pediatr Endocrinol Metab; 2020 Aug; 33(10):1353-1358. PubMed ID: 32866123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iatrogenic vitamin D toxicity in an infant--a case report and review of literature.
    Ketha H; Wadams H; Lteif A; Singh RJ
    J Steroid Biochem Mol Biol; 2015 Apr; 148():14-8. PubMed ID: 25636720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CYP24A1 Mutations in a Cohort of Hypercalcemic Patients: Evidence for a Recessive Trait.
    Molin A; Baudoin R; Kaufmann M; Souberbielle JC; Ryckewaert A; Vantyghem MC; Eckart P; Bacchetta J; Deschenes G; Kesler-Roussey G; Coudray N; Richard N; Wraich M; Bonafiglia Q; Tiulpakov A; Jones G; Kottler ML
    J Clin Endocrinol Metab; 2015 Oct; 100(10):E1343-52. PubMed ID: 26214117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.